Skip to main content
. 2015 Mar 1;9(3):EC06–EC10. doi: 10.7860/JCDR/2015/12581.5630

[Table/Fig-2]:

Gender distribution in the study group

Gender Total number of patients HER2
0 1+ 2+ 3+
Female 24 12(50%) 4(16.7%) 3(12.5%) 5(20.8%)
Male 36 25(69.4%) 0(0%) 0(0%) 11(30.6%)
Total 60 37(61.7%) 4(6.7%) 3(5%) 16(26.7%)

P=0.006**, significant, Fisher Exact test